Study Featured at ASCO 2025 Highlights Potential New Treatment for Aggressive Form of Acute Myeloid Leukemia
May 30, 2025
May 30, 2025
BUFFALO, New York, May 30 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:
* * *
Study Featured at ASCO 2025 Highlights Potential New Treatment for Aggressive Form of Acute Myeloid Leukemia
BUFFALO, N.Y. and CHICAGO -- An international clinical trial co-led by Roswell Park Comprehensive Cancer Center has demonstrated that the investigational drug ziftomenib can produce deep, durable responses in peop . . .
* * *
Study Featured at ASCO 2025 Highlights Potential New Treatment for Aggressive Form of Acute Myeloid Leukemia
BUFFALO, N.Y. and CHICAGO -- An international clinical trial co-led by Roswell Park Comprehensive Cancer Center has demonstrated that the investigational drug ziftomenib can produce deep, durable responses in peop . . .